Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Non-treatment-controlled, Investigator-blinded, Multicenter Study on the Prophylaxis of Early Childhood Symptoms of Atopic Dermatitis in High-risk Children by Continuous Application of a Moisturizing Barrier-stabilizing Skin Cream

NCT04398758 is registered in ClinicalTrials.gov with Infectopharm Arzneimittel GmbH as lead sponsor.

NCT NCT04398758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04398758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Non-treatment-controlled, Investigator-blinded, Multicenter Study on the Prophylaxis of Early Childhood Symptoms of Atopic Dermatitis in High-risk Children by Continuous Application of a Moisturizing Barrier-stabilizing Skin Cream
Lead sponsor
Infectopharm Arzneimittel GmbH
Phase
Phase 3
Overall status
Unknown status
Start date
July 22, 2020
Completion date
June 30, 2024
Enrollment
360 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, infant, newborn